Official ESCRS | European Society of Cataract & Refractive Surgeons
Athens 2016 Registration Programme Exhibitor Information Virtual Exhibition Satellite Meetings
ATHENS escrs


Search Abstracts by author or title
(results will display both Free Papers & Poster)

Intravitreal Bevacizumab for macular edema secondary to branch retinal vein oclusion

Poster Details

First Author: B.Kambo ALBANIA

Co Author(s):    A. Belshi              

Abstract Details


To evaluate the effect of intravitreal bevacizumab on the visual and anatomical outcome in eyes with macular edema secondary to branch retinal vein occlusion.


Laser Eye Clinic Tirana , Albania


A retrospective review was performed for 16 patients with a branch retinal vein occlusion treated with intravitreal bevacizumab. Clinical variables were analyzed, including best-corrected visual acuity, angiographic characteristics and central foveal thickness.


16 eyes were identified with a mean initial best-corrected visual acuity BCVA 0.14 and final best-corrected visual acuity 0.32 after the treatment .The mean initial central foveal thickness of 497 µm decreased to 259 µm . Mean number of injections was 2.5, and mean follow-up was 9 months.


Intravitreal bevacizumab is an effective treatment for macular edema secondary to branch retinal vein occlusion in many subjects. Eyes treated with intravitreal bevacizumab showed a significant reduction in central foveal thickness and improvement in visual acuity. FINANCIAL DISCLOUSRE: NONE

Back to Poster listing